Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer.

Millward, M J

Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jan 1996 - 142-8 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0732-183X

10.1200/JCO.1996.14.1.142 doi


Adult
Aged
Carcinoma, Non-Small-Cell Lung--drug therapy
Confidence Intervals
Disease-Free Survival
Drug Hypersensitivity--etiology
Female
Hematologic Diseases--chemically induced
Humans
Infusions, Intravenous
Lung Neoplasms--drug therapy
Male
Middle Aged
Nervous System Diseases--chemically induced
Paclitaxel--administration & dosage
Survival Rate
Treatment Outcome